Samer Alabed Selected Research

Adenosine (Adenocard)

1/2020	Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.
12/2018	Cochrane corner: adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.
10/2017	Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Samer Alabed Research Topics

Disease

3	Supraventricular Tachycardia 01/2020 - 10/2017
3	Pericarditis 10/2016 - 08/2014
2	Pulmonary Arterial Hypertension 10/2021 - 04/2021
2	Heart Failure 01/2020 - 01/2016
2	Atrial Fibrillation 01/2020 - 12/2019
2	Tardive Dyskinesia 01/2018 - 04/2011
2	Ataxia (Dyssynergia) 01/2018 - 04/2011
2	Mental Disorders (Mental Disorder) 01/2018 - 04/2011
2	Hypotension (Low Blood Pressure) 01/2018 - 10/2017
2	Movement Disorders (Movement Disorder) 01/2018 - 04/2011
2	Psychotic Disorders (Schizoaffective Disorder) 01/2018 - 06/2013
2	Schizophrenia (Dementia Praecox) 01/2018 - 04/2011
2	Seizures (Absence Seizure) 01/2018 - 04/2011
1	Wounds and Injuries (Trauma) 02/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Lung Diseases (Lung Disease) 04/2021
1	Fatigue 01/2020
1	Stroke (Strokes) 12/2019
1	Thrombosis (Thrombus) 12/2019
1	Myocardial Infarction 12/2019
1	Hemorrhage 12/2019
1	Nausea 01/2018
1	Psychomotor Agitation (Akathisia) 01/2018
1	Vomiting 01/2018
1	Confusion (Bewilderment) 01/2018
1	Dizziness (Lightheadedness) 01/2018
1	Neoplasms (Cancer) 04/2017
1	Venous Thromboembolism 10/2016

Drug/Important Bio-Agent (IBA)

3	Adenosine (Adenocard)FDA LinkGeneric 01/2020 - 10/2017
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2020 - 10/2017
3	Colchicine FDA LinkGeneric 10/2016 - 08/2014
2	AnticoagulantsIBA 02/2022 - 12/2019
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2020 - 01/2016
2	progabide (Gabrene)IBA 01/2018 - 04/2011
2	Baclofen FDA LinkGeneric 01/2018 - 04/2011
2	BenzodiazepinesIBA 01/2018 - 04/2011
2	Antipsychotic Agents (Antipsychotics)IBA 01/2018 - 04/2011
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2018 - 04/2011
2	GABA Agonists (GABA Receptor Agonists)IBA 01/2018 - 04/2011
1	Warfarin (Coumadin)FDA LinkGeneric 02/2022
1	Carbon MonoxideIBA 01/2022
1	RivaroxabanIBA 12/2019
1	apixabanIBA 12/2019
1	N(4)-oleylcytosine arabinosideIBA 12/2019
1	Vitamin K FDA Link 12/2019
1	Dabigatran FDA Link 12/2019
1	gamma-Aminobutyric Acid (GABA)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2014
1	gaboxadol (THIP)IBA 04/2011
1	Vigabatrin FDA Link 04/2011
1	MuscimolIBA 04/2011
1	4-amino-5-hexynoic acidIBA 04/2011

Therapy/Procedure

6	Therapeutics 10/2021 - 08/2014
2	Duration of Therapy 01/2020 - 01/2016
2	Percutaneous Coronary Intervention 01/2020 - 12/2019
1	Massage (Zone Therapy) 01/2020
1	Stents 12/2019
1	Palliative Care (Palliative Therapy) 04/2017
1	Drug Therapy (Chemotherapy) 06/2013